Literature DB >> 27335703

Ganoderma Lucidum polysaccharides protect against MPP(+) and rotenone-induced apoptosis in primary dopaminergic cell cultures through inhibiting oxidative stress.

Shan-Shan Guo1, Xiao-Lan Cui1, Wolf-Dieter Rausch2.   

Abstract

Oxidative stress plays a pivotal role in the progressive neurodegeneration in Parkinson's disease (PD) which is responsible for disabling motor abnormalities in more than 6.5 million people worldwide. Polysaccharides are the main active constituents from Ganoderma lucidum which is characterized with anti-oxidant, antitumor and immunostimulant properties. In the present study, primary dopaminergic cell cultures prepared from embryonic mouse mesencephala were used to investigate the neuroprotective effects and the potential mechanisms of Ganoderma lucidum polysaccharides (GLP) on the degeneration of dopaminergic neurons induced by the neurotoxins methyl-4-phenylpyridine (MPP(+)) and rotenone. Results revealed that GLP can protect dopamine neurons against MPP(+) and rotenone at the concentrations of 100, 50 and 25 μg/ml in primary mesencephalic cultures in a dose-dependent manner. Interestingly, either with or without neurotoxin treatment, GLP treatment elevated the survival of THir neurons, and increased the length of neurites of dopaminergic neurons. The Trolox equivalent anti-oxidant capacity (TEAC) of GLP was determined to be 199.53 μmol Trolox/g extract, and the decrease of mitochondrial complex I activity induced by MPP(+) and rotenone was elevated by GLP treatment (100, 50, 25 and 12.5 μg/ml) in a dose dependent manner. Furthermore, GLP dramatically decreased the relative number of apoptotic cells and increased the declining mitochondrial membrane potential (ΔΨm) induced by MPP(+) and rotenone in a dose-dependent manner. In addition, GLP treatment reduced the ROS formation induced by MPP(+) and rotenone at the concentrations of 100, 50 and 25 μg/ml in a dose-dependent manner. Our study indicates that GLP possesses neuroprotective properties against MPP(+) and rotenone neurotoxicity through suppressing oxidative stress in primary mesencephalic dopaminergic cell culture owning to its antioxidant activities.

Entities:  

Keywords:  Ganoderma Lucidum polysaccharides; MPP+; Parkinson’s disease; oxidative stress; rotenone

Year:  2016        PMID: 27335703      PMCID: PMC4913221     

Source DB:  PubMed          Journal:  Am J Neurodegener Dis        ISSN: 2165-591X


  60 in total

1.  Pinocembrin protects SH-SY5Y cells against MPP+-induced neurotoxicity through the mitochondrial apoptotic pathway.

Authors:  Yumin Wang; Junhong Gao; Yingchun Miao; Qifu Cui; Weili Zhao; Junyi Zhang; Hongquan Wang
Journal:  J Mol Neurosci       Date:  2014-01-07       Impact factor: 3.444

2.  Neuroprotection by 6-(methylsulfinyl)hexyl isothiocyanate in a 6-hydroxydopamine mouse model of Parkinson׳s disease.

Authors:  Fabiana Morroni; Giulia Sita; Andrea Tarozzi; Giorgio Cantelli-Forti; Patrizia Hrelia
Journal:  Brain Res       Date:  2014-09-23       Impact factor: 3.252

3.  Anatomic and disease specificity of NADH CoQ1 reductase (complex I) deficiency in Parkinson's disease.

Authors:  A H Schapira; V M Mann; J M Cooper; D Dexter; S E Daniel; P Jenner; J B Clark; C D Marsden
Journal:  J Neurochem       Date:  1990-12       Impact factor: 5.372

4.  The effect of endogenous dopamine in rotenone-induced toxicity in PC12 cells.

Authors:  April A Dukes; Kimberly M Korwek; Teresa G Hastings
Journal:  Antioxid Redox Signal       Date:  2005 May-Jun       Impact factor: 8.401

5.  Rotenone induces cell death in primary dopaminergic culture by increasing ROS production and inhibiting mitochondrial respiration.

Authors:  Khaled Radad; Wolf-Dieter Rausch; Gabriele Gille
Journal:  Neurochem Int       Date:  2006-03-31       Impact factor: 3.921

6.  Kinetic Modeling of the Mitochondrial Energy Metabolism of Neuronal Cells: The Impact of Reduced α-Ketoglutarate Dehydrogenase Activities on ATP Production and Generation of Reactive Oxygen Species.

Authors:  Nikolaus Berndt; Sascha Bulik; Hermann-Georg Holzhütter
Journal:  Int J Cell Biol       Date:  2012-06-10

7.  Ginsenoside Rd Protects SH-SY5Y Cells against 1-Methyl-4-phenylpyridinium Induced Injury.

Authors:  Yang Liu; Ren-Yu Zhang; Jun Zhao; Zheng Dong; Dong-Yun Feng; Rui Wu; Ming Shi; Gang Zhao
Journal:  Int J Mol Sci       Date:  2015-06-24       Impact factor: 5.923

8.  Role of oxidative stress in Parkinson's disease.

Authors:  Onyou Hwang
Journal:  Exp Neurobiol       Date:  2013-03-31       Impact factor: 3.261

9.  Ganoderma lucidum Protects Dopaminergic Neuron Degeneration through Inhibition of Microglial Activation.

Authors:  Ruiping Zhang; Shengli Xu; Yanning Cai; Ming Zhou; Xiaohong Zuo; Piu Chan
Journal:  Evid Based Complement Alternat Med       Date:  2011-06-18       Impact factor: 2.629

Review 10.  Oxidative stress, mitochondrial damage and neurodegenerative diseases.

Authors:  Chunyan Guo; Li Sun; Xueping Chen; Danshen Zhang
Journal:  Neural Regen Res       Date:  2013-07-25       Impact factor: 5.135

View more
  3 in total

Review 1.  Protective Effects of Polysaccharides in Neurodegenerative Diseases.

Authors:  Yinying Wang; Rongsha Chen; Zhongshan Yang; Qian Wen; Xia Cao; Ninghui Zhao; Jinyuan Yan
Journal:  Front Aging Neurosci       Date:  2022-07-04       Impact factor: 5.702

2.  Ganoderma lucidum extract ameliorates MPTP-induced parkinsonism and protects dopaminergic neurons from oxidative stress via regulating mitochondrial function, autophagy, and apoptosis.

Authors:  Zhi-Li Ren; Chao-Dong Wang; Tao Wang; Hui Ding; Ming Zhou; Nan Yang; Yan-Yong Liu; Piu Chan
Journal:  Acta Pharmacol Sin       Date:  2018-07-10       Impact factor: 6.150

3.  EriB targeted inhibition of microglia activity attenuates MPP+ induced DA neuron injury through the NF-κB signaling pathway.

Authors:  Fangfang Dou; Xinkun Chu; Bei Zhang; Liang Liang; Guoqiang Lu; Jianqing Ding; Shengdi Chen
Journal:  Mol Brain       Date:  2018-12-18       Impact factor: 4.041

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.